Načítá se...

Isolation and study of an acquired inhibitor of human coagulation factor V.

A coagulation Factor V inhibitor developed in a man 75 yr of age in association with an anaplastic malignancy and drug treatment (including the aminoglycoside antibiotic, gentamicin). The patient did not bleed abnormally, despite both surgical challenge and plasma Factor V activity of less than 1%....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nesheim, M E, Nichols, W L, Cole, T L, Houston, J G, Schenk, R B, Mann, K G, Bowie, E J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1986
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC423360/
https://ncbi.nlm.nih.gov/pubmed/3944265
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!